Association between atherogenic index of plasma and metabolic dysfunction-associated steatotic liver disease in Egyptian population: a case–control study
Open Access
- 24 September 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 29757
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is hepatic steatosis concurrent with metabolic abnormalities like obesity, insulin resistance, dyslipidemia, and hypertension. We aimed to investigate the association of atherogenic index of plasma with metabolic dysfunction-associated steatotic liver disease (MASLD). The study included 156 MASLD subjects diagnosed by B-ultrasonography having ≥ one of cardiometabolic risk factors while excluding other liver diseases and 144 healthy controls. To all participants; lipid profile, liver enzymes, serum adiponectin and basal insulin level were measured. Calculation of BMI, AIP, LDL cholesterol, Homeostatic model assessment of insulin resistance (HOMA-IR), Fatty liver index (FLI) and Fibrosis-4 (FIB-4) score were done. Receiver operating characteristic curve was drawn to discriminate diagnostic performance of variables. In patients with MASLD, AIP was significantly correlated with increased age, HOMA-IR, FLI, decreased serum adiponectin, and low HDL-C. In multivariate analysis, after adjustment of BMI, LDL-C, HOMA-IR and serum adiponectin, AIP was associated with 3.67 more risk for MASLD (highest OR). To discriminate MASLD, the AUC for AIP was 0.719 (p < 0.001) at cut-off point of > 0.372, while AUC for Combination of AIP and BMI in total MASLD group was 0.865 and for overweight and obese patients was 0.937. Atherogenic index of plasma is independently and positively associated with MASLD, more degree of hepatic steatosis, insulin resistance and low adiponectin level. Using AIP alone or in combination with BMI could alarm clinicians to further investigate for presence of MASLD in individuals at outpatient clinics.Keywords
Funding Information
- Alexandria University
This publication has 44 references indexed in Scilit:
- Longitudinal atherogenic index of plasma trajectories and risk of MASLD progression: A large retrospective cohort studyAnnals of Epidemiology, 2026
- Atherogenic index of plasma identifies subjects with severe liver steatosisScientific Reports, 2025
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology, 2024
- Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLDCurrent Obesity Reports, 2024
- Discovery and quantification of plastic particle pollution in human bloodEnvironment International, 2022
- Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal studyScientific Reports, 2021
- Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factorsAtherosclerosis, 2021
- Hypoadiponectinemia and its Association with Liver Fibrosis in Morbidly Obese PatientsObesity Surgery, 2010
- The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL)Clinical Biochemistry, 2001
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985